Literature DB >> 19228071

Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell.

M Firouz Mohd Mustapa1, Stephanie M Grosse, Laila Kudsiova, Martin Elbs, Eun-Ang Raiber, John B Wong, Anthony P R Brain, Hannah E J Armer, Alice Warley, Melanie Keppler, Tony Ng, M Jayne Lawrence, Stephen L Hart, Helen C Hailes, Alethea B Tabor.   

Abstract

Recent research in the field of nonviral gene delivery vectors has focused on preparing nanoparticles that are stabilized by the incorporation of a PEG coating and where one of the vector components is also cleavable. Here,we describe the synthesis, formulation, transfection properties, and biophysical studies of a PEG-stabilized ternary lipopolyplex vector in which, for the first time, both the lipid and peptide components are designed to be cleaved once the vector has been internalized. A series of cationic lipids, bearing short tri- or hexaethylene glycol groups, attached to the headgroup via an ester linkage, has been prepared. Trifunctional peptides have also been prepared, consisting of a Lys(16) sequence at the N-terminus (to bind and condense plasmid DNA); a spacer group (containing a sequence recognized and cleaved by endosomal enzymes) and an optional PEG4 amino acid; and an integrin-targeting cyclic peptide sequence (allowing the resulting nanoparticle to be internalized via receptor-mediated endocytosis). Differing combinations of these lipids and peptides have been formulated with DOPE and with plasmid DNA, and complex stability, transfection, and cleavage studies carried out. It was shown that optimal transfection activities in a range of cell types and complex stabilities were achieved with lipids bearing short cleavable triethylene glycol moieties, whereas the incorporation of PEG4 amino acids into the cleavable peptides had little effect. We have synthesized appropriate fluorescently labeled components and have studied the uptake of the vector, endosomal escape, peptide cleavage, and plasmid transport to the nucleus in breast cancer cells using confocal microscopy. We have also studied the morphology of these compact, stabilized vectors using cryo-EM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228071     DOI: 10.1021/bc800450r

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  11 in total

1.  Addition of ascorbic acid to the extracellular environment activates lipoplexes of a ferrocenyl lipid and promotes cell transfection.

Authors:  Burcu S Aytar; John P E Muller; Sharon Golan; Shinichi Hata; Hiro Takahashi; Yukishige Kondo; Yeshayahu Talmon; Nicholas L Abbott; David M Lynn
Journal:  J Control Release       Date:  2011-09-22       Impact factor: 9.776

Review 2.  Nanoparticle PEGylation for imaging and therapy.

Authors:  Jesse V Jokerst; Tatsiana Lobovkina; Richard N Zare; Sanjiv S Gambhir
Journal:  Nanomedicine (Lond)       Date:  2011-06       Impact factor: 5.307

Review 3.  Systemic tumor-specific gene delivery.

Authors:  Max Kullberg; Ryan McCarthy; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2013-09-11       Impact factor: 9.776

4.  A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy.

Authors:  Regan J Anderson; Ching-wen Tang; Naomi J Daniels; Benjamin J Compton; Colin M Hayman; Karen A Johnston; Deborah A Knight; Olivier Gasser; Hazel C Poyntz; Peter M Ferguson; David S Larsen; Franca Ronchese; Gavin F Painter; Ian F Hermans
Journal:  Nat Chem Biol       Date:  2014-10-05       Impact factor: 15.040

Review 5.  Clinical review: gene-based therapies for ALI/ARDS: where are we now?

Authors:  James Devaney; Maya Contreras; John G Laffey
Journal:  Crit Care       Date:  2011-06-20       Impact factor: 9.097

6.  Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake.

Authors:  Sarah R MacEwan; Ashutosh Chilkoti
Journal:  Nano Lett       Date:  2014-03-19       Impact factor: 11.189

7.  Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor.

Authors:  G Weitsman; N J Mitchell; R Evans; A Cheung; T L Kalber; R Bofinger; G O Fruhwirth; M Keppler; Z V F Wright; P R Barber; P Gordon; T de Koning; W Wulaningsih; K Sander; B Vojnovic; S Ameer-Beg; M Lythgoe; J N Arnold; E Årstad; F Festy; H C Hailes; A B Tabor; T Ng
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

8.  Development of lipopolyplexes for gene delivery: A comparison of the effects of differing modes of targeting peptide display on the structure and transfection activities of lipopolyplexes.

Authors:  Robin Bofinger; May Zaw-Thin; Nicholas J Mitchell; P Stephen Patrick; Cassandra Stowe; Ana Gomez-Ramirez; Helen C Hailes; Tammy L Kalber; Alethea B Tabor
Journal:  J Pept Sci       Date:  2018-10-16       Impact factor: 1.905

9.  The discovery and enhanced properties of trichain lipids in lipopolyplex gene delivery systems.

Authors:  Atefeh Mohammadi; Laila Kudsiova; M Firouz Mohd Mustapa; Frederick Campbell; Danielle Vlaho; Katharina Welser; Harriet Story; Aristides D Tagalakis; Stephen L Hart; David J Barlow; Alethea B Tabor; M Jayne Lawrence; Helen C Hailes
Journal:  Org Biomol Chem       Date:  2019-01-23       Impact factor: 3.876

10.  Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging.

Authors:  Nick Mitchell; Tammy L Kalber; Margaret S Cooper; Kavitha Sunassee; Samantha L Chalker; Karen P Shaw; Katherine L Ordidge; Adam Badar; Samuel M Janes; Philip J Blower; Mark F Lythgoe; Helen C Hailes; Alethea B Tabor
Journal:  Biomaterials       Date:  2012-11-03       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.